- Home
- TFIN vs VRDN Comparison
TFIN vs VRDN Comparison
Compare TFIN & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- VRDN
- Stock Information
- Founded
- TFIN 1981
- VRDN 2006
- Country
- TFIN United States
- VRDN United States
- Employees
- TFIN N/A
- VRDN N/A
- Industry
- TFIN Major Banks
- VRDN Medical Specialities
- Sector
- TFIN Finance
- VRDN Health Care
- Exchange
- TFIN Nasdaq
- VRDN Nasdaq
- Market Cap
- TFIN 1.5B
- VRDN 1.6B
- IPO Year
- TFIN N/A
- VRDN N/A
- Fundamental
- Price
- TFIN $51.50
- VRDN $12.61
- Analyst Decision
- TFIN Hold
- VRDN Buy
- Analyst Count
- TFIN 6
- VRDN 12
- Target Price
- TFIN $77.50
- VRDN $36.44
- AVG Volume (30 Days)
- TFIN 208.4K
- VRDN 781.0K
- Earning Date
- TFIN 04-16-2025
- VRDN 05-07-2025
- Dividend Yield
- TFIN N/A
- VRDN N/A
- EPS Growth
- TFIN N/A
- VRDN N/A
- EPS
- TFIN 0.54
- VRDN N/A
- Revenue
- TFIN $396,285,000.00
- VRDN $302,000.00
- Revenue This Year
- TFIN $17.60
- VRDN N/A
- Revenue Next Year
- TFIN $12.72
- VRDN $20,553.29
- P/E Ratio
- TFIN $96.02
- VRDN N/A
- Revenue Growth
- TFIN N/A
- VRDN N/A
- 52 Week Low
- TFIN $51.47
- VRDN $11.40
- 52 Week High
- TFIN $110.58
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- TFIN 23.20
- VRDN 31.20
- Support Level
- TFIN $56.50
- VRDN $14.03
- Resistance Level
- TFIN $59.53
- VRDN $15.91
- Average True Range (ATR)
- TFIN 2.68
- VRDN 0.69
- MACD
- TFIN -0.26
- VRDN -0.21
- Stochastic Oscillator
- TFIN 0.70
- VRDN 16.82
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.